PUBLICATIONS · 10470696
Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet
- Publication date
- 1999 Aug 14
- First author
- Source null
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet 1999 Nov 6;354(9190):1650
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- Lancet. 1999 Aug 14;354(9178):526-7. doi: 10.1016/S0140-6736(99)00210-X.
- note
- Source null
- related pmid
- 10470689
- relationship
- Comment in
Authors and identifiers
Complete bibliographic record and source provenance
- authors
- bibliography ids
- nci-bib-f2bd413ad1c5b9b9c1cd121d
- book metadata
- content sha256
- 703b392a30955dc6afa40bbc74c9c683caf50363e50b23f98aa7a72b9bef587e
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:10470696
- immutable id
- pubmed:10470696@703b392a30955dc6afa40bbc74c9c683caf50363e50b23f98aa7a72b9bef587e
- journal
- abbreviation
- Lancet
- issn electronic
- Source null
- issn print
- 0140-6736
- issue
- 9178
- name
- Lancet (London, England)
- nlm unique id
- 2985213R
- pages
- 533-40
- volume
- 354
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet 1999 Nov 6;354(9190):1650
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- citation
- Lancet. 1999 Aug 14;354(9178):526-7. doi: 10.1016/S0140-6736(99)00210-X.
- note
- Source null
- related pmid
- 10470689
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 10470696
- provenance
- batch id
- 322200bb755447812cbb
- provider
- NCBI PubMed ESummary
- record sha256
- f33d60f3c9042dd60d7b3810c0b89db215a031be8fe689c5f7027286cd50a311
- response sha256
- 943a99f9971dfe66ed403e5c181642ea57c7276fe995e9a6a8c892602df084fa
- retrieved at
- 2026-09-09T23:45:33.802271+00:00
- publication date
- display
- 1999 Aug 14
- precision
- day
- year
- 1999
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Preserved source evidence · Not medical advice
Triangle